Personal experience with the application of carbohydrate-deficient transferrin (CDT) assays to the detection of congenital disorders of glycosylation

被引:9
作者
Colomé, C
Ferrer, I
Artuch, R
Vilaseca, MA
Pineda, M
Briones, P
机构
[1] Univ Barcelona, Hosp Sant Joan de Deu, Serv Bioquim, Barcelona, Spain
[2] Hosp Sant Joan de Deu Clin, Unitat Integrada, Serv Neuropediat, Barcelona, Spain
[3] CSIC, Corp Sanitaria, Inst Bioquim Clin, Barcelona, Spain
关键词
carbohydrate-deficient transferrin; congenital disorders of glycosylation; sialotransferrin; sialic acid; glycoprotein; inborn error;
D O I
10.1515/CCLM.2000.143
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Congenital disorders of glycosylation (CDG) are genetic multisystemic diseases due to various defects in the biosynthesis or processing of glycoproteins. Our aim is to present our experience in the selective screening of CDG syndrome in a paediatric population (421 patients) with clinical suspicion of the disease, analysing serum carbohydrate-deficient transferrin (CDT) by radioimmunoassay and/or immunoturbidimetry. We established the normal values for our paediatric population. The abnormal results were confirmed and classified by isoelectric focusing of serum sialotransferrins, and by enzymatic and molecular studies. We found 14 patients (3.3%) with abnormal serum CDT; 11 of them were classified as CDG type Ia (CDG-Ia) and the other three showed altered isoelectrofocusing patterns but remain untyped and are under investigation. In conclusion, both CDT assays proved to be useful tools for CDG screening. Isoelectric focusing is a simple procedure but it requires specific instruments that are not always available. Since the immunoturbidimetric procedure is commonly used to monitor for recent excessive alcohol consumption in clinical laboratories and does not require special equipment, it may also be reliably used to screen for CDG in children under clinical suspicion.
引用
收藏
页码:965 / 969
页数:5
相关论文
共 29 条
[1]   Phosphomannomutase deficiency and normal pubertal development [J].
Artigas, J ;
Cardo, E ;
Pineda, M ;
Nosas, R ;
Jaeken, J .
JOURNAL OF INHERITED METABOLIC DISEASE, 1998, 21 (01) :78-79
[2]  
Bean P, 1997, CLIN CHEM, V43, P983
[3]  
CARRATALA F, 1999, REV NEUROL, V29, P567
[4]  
de Michelena MI, 1999, AM J MED GENET, V84, P481
[5]   A novel disorder caused by defective biosynthesis of N-linked oligosaccharides due to glucosidase I deficiency [J].
De Praeter, CM ;
Gerwig, GJ ;
Bause, E ;
Nuytinck, LK ;
Vliegenthart, JFG ;
Breuer, W ;
Kamerling, JP ;
Espeel, MF ;
Martin, JJR ;
De Paepe, AM ;
Chan, NWC ;
Dacremont, GA ;
Van Coster, RN .
AMERICAN JOURNAL OF HUMAN GENETICS, 2000, 66 (06) :1744-1756
[6]   Disorders in protein glycosylation and potential therapy: Tip of an iceberg? [J].
Freeze, HH .
JOURNAL OF PEDIATRICS, 1998, 133 (05) :593-600
[7]  
Grünewald S, 2000, ANN NEUROL, V47, P776
[8]  
Helander A, 1999, CLIN CHEM, V45, P131
[9]   Multi-allelic origin of congenital disorder of glycosylation (CDG)-Ic [J].
Imbach, T ;
Grünewald, S ;
Schenk, B ;
Burda, P ;
Schollen, E ;
Wevers, RA ;
Jaeken, J ;
de Klerk, JBC ;
Berger, EG ;
Matthijs, G ;
Aebi, M ;
Hennet, T .
HUMAN GENETICS, 2000, 106 (05) :538-545
[10]   Deficiency of dolichol-phosphate-mannose synthase-1 causes congenital disorder of glycosylation type Ie [J].
Imbach, T ;
Schenk, B ;
Schollen, E ;
Burda, P ;
Stutz, A ;
Grünewald, S ;
Bailie, NM ;
King, MD ;
Jaeken, J ;
Matthijs, G ;
Berger, EG ;
Aebi, M ;
Hennet, T .
JOURNAL OF CLINICAL INVESTIGATION, 2000, 105 (02) :233-239